ALGS vs MA · rev $3.6M vs P/E 38, rev $32.79B
Aligos Therapeutics Inc (ALGS) versus Mastercard Inc (MA) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported MA revenue for 2025-12-31 was $32.79B. Net income was $14.97B. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. MA currently screens at market cap $515.12B and trailing P/E 38.4.
ALGS currently screens at market cap $44.1M. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Not investment advice. Open the ALGS and MA stock pages for the full models.
Not investment advice.